3B BlackBio Dx (BOM:532067) FCF Margin %: 0.00% (As of Mar. 2026)


BOM:532067 3B BlackBio Dx Ltd BOM:532067
63 GF Score
Price ₹1,197.70
GF Value ₹2,104.57
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is 3B BlackBio Dx FCF Margin %?

3B BlackBio Dx BOM:532067 +2.49% 63 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates BOM:532067 with a GF Score™ of 63/100 and a GF Value™ of ₹2,104.57 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 955 Biotechnology companies, 3B BlackBio Dx ranks better than 88.48% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. 3B BlackBio Dx's Free Cash Flow for the three months ended in Mar. 2026 was ₹0 Mil. 3B BlackBio Dx's Revenue for the three months ended in Mar. 2026 was ₹354 Mil. Therefore, 3B BlackBio Dx's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, 3B BlackBio Dx's current FCF Yield % is 2.61%.

The historical rank and industry rank for 3B BlackBio Dx's FCF Margin % or its related term are showing as below:

BOM:532067' s FCF Margin % Range Over the Past 10 Years
Min: -3.76   Med: 26.03   Max: 44.01
Current: 19

During the past 13 years, the highest FCF Margin % of 3B BlackBio Dx was 44.01%. The lowest was -3.76%. And the median was 26.03%.

BOM:532067's FCF Margin % is ranked better than
88.48% of 955 companies
in the Biotechnology industry
Industry Median: -84.65 vs BOM:532067: 19.00

3B BlackBio Dx FCF Margin % Related Terms

3B BlackBio Dx FCF Margin % Historical Data

* Premium members only.

The historical data trend for 3B BlackBio Dx's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3B BlackBio Dx FCF Margin % Chart

3B BlackBio Dx Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.48 29.53 35.67 44.01 19.00

3B BlackBio Dx Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BOM:532067 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, 3B BlackBio Dx's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3B BlackBio Dx FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3B BlackBio Dx's FCF Margin % distribution charts can be found below:

* The bar in red indicates where 3B BlackBio Dx's FCF Margin % falls into.


BOM:532067
63GF Score
3B BlackBio Dx Ltd BOM:532067
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

3B BlackBio Dx FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

3B BlackBio Dx's FCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=269.662/1419.181
=19.00 %

3B BlackBio Dx's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0/354.341
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
3B BlackBio Dx (BOM:532067) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on 3B BlackBio Dx and its competitors. According to the industry distribution chart, 3B BlackBio Dx ranks #110 out of 955 companies in the Biotechnology industry, placing it in the top 11.5%.
Is 3B BlackBio Dx's FCF Margin % too high?
3B BlackBio Dx's current FCF Margin % is 0.00%. Based on the distribution chart, 3B BlackBio Dx ranks #110 out of 955 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, 3B BlackBio Dx has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does 3B BlackBio Dx's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, 3B BlackBio Dx ranks #110 out of 955 companies for FCF Margin %. This places 3B BlackBio Dx in the top 12% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on 3B BlackBio Dx and its competitors. 3B BlackBio Dx's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3B BlackBio Dx stock overvalued right now?
Based on GuruFocus' analysis, 3B BlackBio Dx (BOM:532067) is currently considered Possible Value Trap. The stock's GF Value™ is ₹2,104.57, compared to a current price of ₹1,197.70 — trading 43.1% below its estimated fair value. The current FCF Margin % is 0.00%. 3B BlackBio Dx's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For 3B BlackBio Dx (BOM:532067), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 3B BlackBio Dx (BOM:532067) Overvalued in 2026?

Based on GuruFocus' analysis, 3B BlackBio Dx stock appears to be undervalued. The current stock price of ₹1,197.70 is trading 43.1% below its estimated GF Value™ of ₹2,104.57. GuruFocus considers 3B BlackBio Dx to be Possible Value Trap.

Key valuation signals for BOM:532067:

  • FCF Margin %: 0.00%
  • GF Value™: ₹2,104.57 vs. price of ₹1,197.70 (43.1% below fair value)
  • GF Score™: 63/100 with 2 warning signs

No single metric tells the full story. See the BOM:532067 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

3B BlackBio Dx Business Description

Address 7-C, Industrial Area, Govindpura, Bhopal, MP, IND, 462023
3B BlackBio Dx Ltd is an Indian company specializing in PCR-based Molecular Diagnostic Kits. The company is involved in designing, developing, manufacturing, and commercializing PCR-based Molecular Diagnostic kits, PCR Enzymes, and PCR Reagents.
63GF Score

Get the complete analysis for BOM:532067

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,197.70
Price
₹2,104.57
GF Value